Internal Medicine, Hematology & Oncology · Anaheim, CA
NPI
1083602155
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1801 W Romneya Dr Ste 203
Anaheim, CA, 92801
Phone (714) 999-1465
Groups this clinician bills Medicare through
Medicare paid, 2024
$803K
41,614 services
Medicare patients, 2024
598
Average age 75
Drug cost, 2024
$2.8M
1,162 prescriptions
Company payments, 2025
$5,118
From 53 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jayaram S Bharadwaj was code J0897 (injection, denosumab, 1 mg), 4,513 times for 40 patients. In total Jayaram S Bharadwaj billed 41,614 services in 84 codes, and Medicare paid $803K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,513 | 40 | $20.55 | $93K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,180 | 35 | $0.09 | $106 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,100 | 11 | $15.82 | $17K |
| 99214 Office E&M - Established | Office | 673 | 357 | $111.76 | $75K |
| 85025 Blood Count | Office | 548 | 306 | $7.61 | $4,170 |
| 36415 Venipuncture Blood Collection | Office | 533 | 305 | $8.64 | $4,603 |
| 99233 Hospital E&M - Subsequent | Facility | 257 | 119 | $105.26 | $27K |
| 96127 Behavioral Health Services | Office | 240 | 204 | $3.74 | $897 |
| 96372 Injection Administration | Office | 222 | 94 | $13.24 | $2,939 |
| 99213 Office E&M - Established | Office | 118 | 83 | $78.84 | $9,303 |
| 96367 Intravenous Infusion, Hydration | Office | 117 | 38 | $27.02 | $3,161 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 90 | 35 | $0.65 | $58.73 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 88 | 42 | $0.98 | $85.95 |
| 96413 Chemotherapy Administration | Office | 83 | 27 | $126.84 | $11K |
| 99223 Hospital E&M - Initial | Facility | 63 | 63 | $154.18 | $9,713 |
By year: 2022 $406K for 37,941 services; 2023 $325K for 22,201 services; 2024 $803K for 41,614 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 548 | 306 | $7.61 | $4,170 |
| 36415 Venipuncture Blood Collection | 533 | 305 | $8.64 | $4,603 |
Medicare prescription drug claims, 2024
In 2024, the drug Jayaram S Bharadwaj prescribed most often to Medicare patients was Diphenhydramine Hcl, with 64 prescriptions and refills. In total Jayaram S Bharadwaj wrote 1,162 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diphenhydramine Hcl Generic | 64 | 65 | 20 | $117 |
| Famotidine Generic | 58 | 62 | 17 | $114 |
| Procrit Epoetin Alfa | 55 | 55 | Under 11 | $88K |
| Exemestane Generic | 52 | 79 | 15 | $7,269 |
| Xgeva Denosumab | 51 | 57 | Under 11 | $159K |
| Dexamethasone Sodium Phosphate Generic | 50 | 51 | 17 | $158 |
| Palonosetron Hcl Generic | 36 | 36 | Under 11 | $676 |
| Zarxio Filgrastim-Sndz | 33 | 33 | 11 | $52K |
| Hydroxyurea Generic | 26 | 38 | Under 11 | $225 |
| Prednisone Generic | 26 | 26 | Under 11 | $80.53 |
| Neulasta Pegfilgrastim | 25 | 25 | Under 11 | $164K |
| Anastrozole Generic | 24 | 62 | 12 | $386 |
| Zoledronic Acid Generic | 24 | 47 | Under 11 | $2,113 |
| Tagrisso Osimertinib Mesylate | 24 | 24 | Under 11 | $370K |
| Xtandi Enzalutamide | 23 | 23 | Under 11 | $328K |
Brand drugs: - claims; generic drugs: 709 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jayaram S Bharadwaj $5,118 ($5,118 in general payments such as food, travel and fees) from 53 companies. The largest payer was Merck Sharp & Dohme LLC with $345.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 14 | $345 |
| Janssen Biotech, Inc. JNJ | 11 | $285 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $280 |
| Incyte Corporation INCY | 9 | $262 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $249 |
| Pfizer Inc. PFE | 11 | $235 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $220 |
| Abbvie Inc. ABBV | 12 | $203 |
| Celgene Corporation BMY | 16 | $186 |
| Daiichi Sankyo Inc. 4568.T | 8 | $179 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.